Defective B cell tolerance checkpoints in systemic lupus erythematosus.
A cardinal feature of systemic lupus erythematosus (SLE) is the development of autoantibodies. The first autoantibodies described in patients with SLE were those specific for nuclei and DNA, but subsequent work has shown that individuals with this disease produce a panoply of different autoantibodies. Thus, one of the constant features of SLE is a profound breakdown in tolerance in the antibody system. The appearance of self-reactive antibodies in SLE precedes clinical disease, but where in the B cell pathway tolerance is first broken has not been defined. In healthy humans, autoantibodies are removed from the B cell repertoire in two discrete early checkpoints in B cell development. We found these checkpoints to be defective in three adolescent patients with SLE. 25-50% of the mature naive B cells in SLE patients produce self-reactive antibodies even before they participate in immune responses as compared with 5-20% in controls. We conclude that SLE is associated with abnormal early B cell tolerance.
Yurasov
Sergey
S
Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
Wardemann
Hedda
H
Hammersen
Johanna
J
Tsuiji
Makoto
M
Meffre
Eric
E
Pascual
Virginia
V
Nussenzweig
Michel C
MC
D000293:Adolescent; D001323:Autoantibodies / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology* / Q000473:pathology; D002460:Cell Line; D002648:Child; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D008297:Male; D010718:Phosphatidylserines / Q000276:immunology / Q000378:metabolism
D001323:Autoantibodies; D010718:Phosphatidylserines
Autoimmunity. 2000;33(1):61-76
11204254
Annu Rev Immunol. 2001;19:275-90
11244038
Immunology. 2001 Mar;102(3):273-80
11298825
N Engl J Med. 2001 Aug 2;345(5):340-50
11484692
Nat Immunol. 2001 Sep;2(9):764-6
11526379
J Clin Invest. 2001 Sep;108(6):879-86
11560957
Immunity. 2001 Sep;15(3):397-408
11567630
J Clin Invest. 2001 Oct;108(7):1061-70
11581307
Science. 2001 Nov 16;294(5546):1540-3
11711679
Nat Immunol. 2001 Dec;2(12):1089-90
11725293
Arthritis Rheum. 2001 Dec;44(12):2715-27
11762931
Nature. 2002 Apr 11;416(6881):603-7
11948342
J Exp Med. 2002 Sep 2;196(5):655-65
12208880
J Exp Med. 1994 Apr 1;179(4):1317-30
7511686
EMBO J. 1994 Jul 1;13(13):2951-62
8039491
J Exp Med. 1994 Sep 1;180(3):885-95
8064239
Nature. 1994 Sep 29;371(6496):389-95
7522305
J Immunol. 1995 May 1;154(9):4526-35
7722307
Cell. 1996 May 3;85(3):303-6
8616885
Nature. 1996 Jun 27;381(6585):751-8
8657279
J Clin Invest. 1996 Oct 15;98(8):1843-50
8878436
Arthritis Rheum. 1997 Sep;40(9):1725
9324032
J Clin Invest. 1997 Nov 15;100(10):2538-46
9366568
N Engl J Med. 1998 May 7;338(19):1359-68
9571257
J Exp Med. 1998 Jul 20;188(2):387-92
9670050
J Clin Invest. 1998 Aug 15;102(4):688-94
9710436
J Exp Med. 1998 Nov 2;188(9):1679-89
9802980
J Exp Med. 1998 Nov 2;188(9):1691-703
9802981
J Immunol. 1999 May 15;162(10):6060-70
10229847
J Immunol. 1999 Jul 15;163(2):1027-36
10395701
J Exp Med. 1999 Jul 5;190(1):75-89
10429672
Clin Immunol. 1999 Aug;92(2):188-96
10444363
Science. 1957 Jul 26;126(3265):162-3
13442661
Immunol Rev. 2000 Aug;176:86-104
11043770
Immunity. 2003 Feb;18(2):185-92
12594946
Science. 2003 Sep 5;301(5638):1374-7
12920303
N Engl J Med. 2003 Oct 16;349(16):1526-33
14561795
Nat Immunol. 2003 Nov;4(11):1057-64
14586424
J Exp Med. 1999 Dec 6;190(11):1697-710
10587360
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2743-8
10688906
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3370-5
10716715
Nature. 2000 Apr 27;404(6781):995-9
10801128
Nat Genet. 2000 Jun;25(2):135-6
10835621
Immunol Rev. 2000 Jun;175:33-46
10933589
Int Arch Allergy Immunol. 2000 Sep;123(1):36-45
11014970
J Immunol. 2000 Nov 15;165(10):5970-9
11067960
Immunity. 2003 Dec;19(6):837-47
14670301
J Exp Med. 2004 Jan 5;199(1):145-50
14699083
Int Arch Allergy Immunol. 2004 Jan;133(1):72-83
14726634
Immunity. 2004 Apr;20(4):441-53
15084273
Immunity. 2004 Jun;20(6):785-98
15189742
Curr Opin Pharmacol. 2004 Aug;4(4):347-54
15251127
Blood. 2004 Sep 15;104(6):1711-5
15166038
Proc Natl Acad Sci U S A. 1975 Feb;72(2):418-22
1054824
Adv Immunol. 1985;37:269-390
3890479
Nature. 1987 Aug 27-Sep 2;328(6133):805-11
3498121
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9150-4
3480535
Nature. 1988 Aug 25;334(6184):676-82
3261841
Nature. 1989 Feb 9;337(6207):562-6
2783762
Adv Immunol. 1989;44:93-151
2646863
J Exp Med. 1991 Jun 1;173(6):1357-71
1903427
Nature. 1991 Nov 28;354(6351):308-11
1956380
Blood. 1992 Jun 15;79(12):3369-79
1375851
J Exp Med. 1993 Apr 1;177(4):1009-20
8459201
J Exp Med. 1993 Apr 1;177(4):999-1008
8459227
J Immunol. 1993 Jun 1;150(11):4966-77
8496598
J Exp Med. 1994 Jan 1;179(1):125-34
8270860